Genertec Universal Medical Group Company Ltd Financials

Market Capitalization HK$12.61 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	5.02
Forward PE	4.74
Price to Sales TTM	HK$0.84
Price to Book MRQ	HK$0.54
Enterprise to Revenue	4.53
Enterprise to EBITDA	18.42

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	15.23%
Operating Margin	21.53%
Return on Assets TTM	2.76%
Return on Equity TTM	10.38%

Income Statement

Revenue TTM	HK$15,989,873,012
Revenue per Share TTM	HK$7.60
Quarterly Revenue Growth	17.00%
Gross Profit TTM	HK$5,125,366,255
EBITDA	HK$3,932,235,939
Net Income to Common TTM	HK$2,360,330,949
Diluted EPS TTM	HK$1.19
Quarterly Earnings Growth YoY	7.30%

Balance Sheet

Total Cash MRQ	HK$2,522,706,788
Total Cash per Share MRQ	HK$1.20
Total Debt MRQ	HK$
Total Debt to Equity MRQ	228.02
Current Ratio MRQ	2.69
Book Value per Share MRQ	HK$11.04

Cash Flow

Operating Cash Flow TTM	HK$6,215,143,947
Levered Free Cash Flow TTM	HK$2,259,254,245

2666 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	1,891,539,661
Float Shares	1,167,533,940
Avg 10 Volume	4,273,872
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	40.50%
% Held by Institutions	24.00%

Stock Price Summary

Beta	0.64
Fifty Two Week Low	HK$4.59
Fifty Two Week High	HK$6.71
Fifty Two Week Change	19.43%
Day 50 MA	HK$6.29
Day 200 MA	HK$5.87

Dividends and Splits

Forward Annual Dividend Rate	HK$1.40
Forward Annual Dividend Yield	23.45%
Trailing Annual Dividend Rate	HK$0.35
Trailing Annual Dividend Yield	5.86%
Payout Ratio	29.89%
Dividend Date
Ex Dividend Date	2025-06-12
Last Split Factor
Last Split Date